Dr Desai on the Efficacy of Divarasib Plus Cetuximab in KRAS G12C–Mutant CRC
Jayesh Desai, MBBS, FRACP, discusses efficacy data for the combination of divarasib plus cetuximab in patients with colorectal cancer harboring a KRAS G12C mutation from a phase 1B study.
Source: onclive.com